Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pentoxifylline
Cat. No.:
OB0225LY-0295
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Pentoxifylline is a substrate with properties that improve blood circulation and viscosity.
Synonym:
Oxpentifylline; PTX; BL-191; 6493-05-6; Pentoxifyllin; Dimethyloxohexylxanthine; 3,7-Dimethyl-1-(5-oxohexyl)xanthine; 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-; 1-(5-Oxohexyl)theobromine; Rentylin; 3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
CAS No.:
6493-05-6
Compound CID:
4740
Formula:
C13H18N4O3
Formula Weight:
278.31
Specification
Relative Density:
1.1713 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pentoxifyllinet can be used to study blood rheology or play an important role in modeling diabetes-related complications.
Library Information
Targets:
Adenosine receptor; PDE
Receptors:
A2 receptor
Pathways:
Metabolism; GPCR/G protein; Autophagy; Neuronal signaling; Microbiology/Virology; Proteases/Proteasome
Plate Number:
AOCL-4
Plate Location:
g6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
18.33 mg/mL; 65.87 mM
Water Max Solubility:
197.6 mM
